Tweet Archive for January 2012 « page 3
#imcas2012 Tribune. Recombinant technology for botulinum toxin offers promises beyond current products. Ipsen. Neurotoxin BoNT A.
#imcas2012 Tribune. Big news! in the future Dysport will be available in a liquid formulation (no reconstitution). Ipsen. Neurotoxin
#imcas2012 Tribune. Little explanations how the industry plan to approach consumers/patients. How can they establish link brand & consumer
#imcas2012 very interesting data ATX 101 (injectable for reduction localized fat) presented by Gary Monheit. Unique CT programme Phase 2 & 3
#imcas2012 animal model presented for laser assisted delivery mesenchymal stem cells (MSCs)
#imcas2012 next step for topical BoNT A is comparative trial vs injected BoNT A
#imcas2012 nanoparticule (peptide carrier) able to drag large molecule through skin membrane
#imcas2012 topical BoNT A for hyperhidrosis also seems to have some effect. More RCT needed
#imcas2012 also presentation of topical BoNT A
#imcas2012 topical Restylane CT seems to have some effect